W. K. Alfred Yung
W. K. Alfred Yung
Подтвержден адрес электронной почты в домене mdanderson.org
Название
Процитировано
Процитировано
Год
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
Cancer Genome Atlas (TCGA) Research Network
Nature 455 (7216), 1061, 2008
58682008
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23. 3 that is mutated in multiple advanced cancers
PA Steck, MA Pershouse, SA Jasser, WKA Yung, H Lin, AH Ligon, ...
Nature genetics 15 (4), 356-362, 1997
39201997
The somatic genomic landscape of glioblastoma
CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ...
Cell 155 (2), 462-477, 2013
35392013
Bevacizumab alone and in combination with irinotecan in recurrent glioblastoma
HS Friedman, MD Prados, PY Wen, T Mikkelsen, D Schiff, LE Abrey, ...
Journal of clinical oncology 27 (28), 4733-4740, 2009
24862009
Molecular profiling reveals biologically discrete subsets and pathways of progression in diffuse glioma
M Ceccarelli, FP Barthel, TM Malta, TS Sabedot, SR Salama, BA Murray, ...
Cell 164 (3), 550-563, 2016
13302016
Outcomes and prognostic factors in recurrent glioma patients enrolled onto phase II clinical trials
ET Wong, KR Hess, MJ Gleason, KA Jaeckle, AP Kyritsis, MD Prados, ...
Journal of Clinical Oncology 17 (8), 2572-2572, 1999
10131999
A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo
J Fueyo, C Gomez-Manzano, R Alemany, PSY Lee, TJ McDonnell, ...
Oncogene 19 (1), 2-12, 2000
8942000
Multicenter phase II trial of temozolomide in patients with anaplastic astrocytoma or anaplastic oligoastrocytoma at first relapse
WKA Yung, MD Prados, R Yaya-Tur, SS Rosenfeld, M Brada, ...
Journal of Clinical Oncology 17 (9), 2762-2771, 1999
8581999
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines
DHF Teng, R Hu, H Lin, T Davis, D Iliev, C Frye, B Swedlund, KL Hansen, ...
Cancer research 57 (23), 5221-5225, 1997
6371997
PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis
W Yang, Y Xia, D Hawke, X Li, J Liang, D Xing, K Aldape, T Hunter, ...
Cell 150 (4), 685-696, 2012
6142012
Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas
HA Fine, WD Figg, K Jaeckle, PY Wen, AP Kyritsis, JS Loeffler, VA Levin, ...
Journal of Clinical Oncology 18 (4), 708-708, 2000
5672000
FoxM1 promotes β-catenin nuclear localization and controls Wnt target-gene expression and glioma tumorigenesis
N Zhang, P Wei, A Gong, WT Chiu, HT Lee, H Colman, H Huang, J Xue, ...
Cancer cell 20 (4), 427-442, 2011
5022011
Phase I/II study of imatinib mesylate for recurrent malignant gliomas: North American Brain Tumor Consortium Study 99-08
PY Wen, WKA Yung, KR Lamborn, PL Dahia, Y Wang, B Peng, LE Abrey, ...
Clinical Cancer Research 12 (16), 4899-4907, 2006
4682006
Phase I trial of adenovirus-mediated p53 gene therapy for recurrent glioma: biological and clinical results
FF Lang, JM Bruner, GN Fuller, K Aldape, MD Prados, S Chang, ...
Journal of Clinical Oncology 21 (13), 2508-2518, 2003
4442003
Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis
T Sano, H Lin, X Chen, LA Langford, D Koul, ML Bondy, KR Hess, ...
Cancer research 59 (8), 1820-1824, 1999
4261999
Progression-free survival: an important end point in evaluating therapy for recurrent high-grade gliomas
KR Lamborn, WKA Yung, SM Chang, PY Wen, TF Cloughesy, ...
Neuro-oncology 10 (2), 162-170, 2008
4092008
Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN
MA Davies, D Koul, H Dhesi, R Berman, TJ McDonnell, D McConkey, ...
Cancer Research 59 (11), 2551-2556, 1999
3941999
Epidermal growth factor receptor variant III status defines clinically distinct subtypes of glioblastoma
CE Pelloski, KV Ballman, AF Furth, L Zhang, E Lin, EP Sulman, K Bhat, ...
Journal of Clinical Oncology 25 (16), 2288-2294, 2007
3552007
Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma
JM Nigro, A Misra, L Zhang, I Smirnov, H Colman, C Griffin, N Ozburn, ...
Cancer research 65 (5), 1678-1686, 2005
3542005
The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires
D Osoba, NK Aaronson, M Muller, K Sneeuw, MA Hsu, WKA Yung, ...
Quality of Life Research 5 (1), 139-150, 1996
3341996
В данный момент система не может выполнить эту операцию. Повторите попытку позднее.
Статьи 1–20